Neuronetics, Inc.
STIM
$1.24
-$0.04-3.13%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -17.53% | 12.01% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -17.53% | 12.01% | |||
| Cost of Revenue | -6.98% | -2.56% | |||
| Gross Profit | -26.92% | 29.20% | |||
| SG&A Expenses | -5.17% | 9.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.40% | 4.04% | |||
| Operating Income | -93.73% | 36.58% | |||
| Income Before Tax | -49.60% | 23.35% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -49.60% | 23.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -120.83% | -86.52% | |||
| Net Income | -50.74% | 20.86% | |||
| EBIT | -93.73% | 36.58% | |||
| EBITDA | -110.11% | 38.83% | |||
| EPS Basic | -48.99% | 22.54% | |||
| Normalized Basic EPS | -50.49% | 25.37% | |||
| EPS Diluted | -48.99% | 22.54% | |||
| Normalized Diluted EPS | -50.49% | 25.37% | |||
| Average Basic Shares Outstanding | 1.21% | 2.15% | |||
| Average Diluted Shares Outstanding | 1.21% | 2.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||